CIR.L Share News (CIR)

UK Earnings, Trading Statements Calendar - Week Ahead

Wednesday broker round-up UPDATE

Ashtead Group: Barclays ups target price from 930p to 946p retaining its overweight rating. Berkeley Group: Numis upgrades from hold to buy with a target price of 2491p. Brown (N) Group: Oriel places its buy recommendation under review. BT Group: Jefferies ups target price from 440p to 470p and k

Circassia Pharmaceuticals Sees Positive Results From Allergy Study

LONDON (Alliance News) - Circassia Pharmaceuticals PLC said Friday it has seen positive results from a two-year follow up of a phase IIb study of a house dust mite allergy product HDM-SPIRE. Investigators reassessed patients' allergy symptoms two years after starting treatment with the prod

Imperial Innovation Looks To Raise GBP150.0 Million In Share Placing

LONDON (Alliance News) - Imperial Innovations Group PLC Monday detailed plans to raise up to GBP150.0 million before expenses through a share placing with new and existing investors, as it looks to support its existing portfolio companies, source opportunities to invest in new technologies, and f

Circassia Pharmaceuticals Funded To Progress With Allergy Treatments

LONDON (Alliance News) - Clinical-stage specialty biopharmaceutical company Circassia Pharmaceuticals PLC Monday said it is fully-funded to continue the development of its SPIRE product portfolio and bringing CAT-SPIRE to the market after raising over GBP200 million though an initial public offer

DIRECTOR DEALINGS: Circassia Phamaceuticals CEO, Non-Executive Transfer Shares

LONDON (Alliance News) - Circassia Pharmaceuticals PLC Tuesday said Chief Executive Steven Harris and non-executive Director Charles Swingland transfered shares into family trusts Thursday.

Details are as follows.

18 Mar 2014 14:00

Dalata Hotel Group IPO Oversubscribed

LONDON (Alliance News) - Dalata Hotel Group PLC Tuesday said it has raised EUR265 million gross through a placing of 106 million shares under its float on AIM, with the net proceeds earmarked for the acquisition of a portfolio of 16 to 25 hotels throughout Ireland and to pay down its debt.

Read more

13 Mar 2014 10:04

Circassia Pharmaceuticals hails 'biggest ever' UK biotech IPO

Allergy treatment developer Circassia Pharmaceuticals has confirmed it is raising 200m pounds in its initial public offering, as conditional trading between brokers began on Thursday morning. The biotech firm, which was spun out of university technology transfer group Imperial Innovations, priced

Read more